Search results
12 wrz 2023 · Y90 radioembolization is a minimally invasive procedure that places radioactive beads into a blood vessel near your liver to block your tumor’s blood supply and destroy its cells. It may help increase the survival time of some people with liver cancer that can’t be surgically removed, but it has low overall survival rates and potential complications.
3 paź 2023 · Overall, Y-90 treatment is a promising option for patients with liver cancer. This safe, effective treatment can help improve patient outcomes with this challenging disease. If you or a loved one has been diagnosed with liver cancer, ask your health care team if Y-90 treatment may be right for you.
14 lip 2023 · Y-90 is a type of transarterial therapy that uses radioactive beads to target and kill liver tumors. Learn how Y-90 works, what to expect and how it can be combined with other treatments.
3 dni temu · Researchers found that a higher dosage of radioembolization treatment using yttrium (Y)-90 microspheres than previously recommended may benefit patients with hepatocellular carcinoma, according to a recent study published by Chen et al in Liver Cancer. The findings could be practice-changing. Background
3 paź 2023 · Radiation segmentectomy has become a viable alternative to thermal ablation for early-stage HCC (Barcelona Clinic Liver Cancer 0 and A) and has been commonly used as a bridge to transplant. TARE is also commonly used for downstaging to transplant using traditional lobar dosimetry and radiation segmentectomy techniques.
20 wrz 2021 · To study the impact of transarterial Yttrium-90 radioembolization (TARE) in combination with second-line systemic chemotherapy for colorectal liver metastases (CLM). Methods.
29 mar 2016 · Yttrium-90 (90 Y) microsphere radioembolization is a promising treatment modality that has emerged for the management of patients with liver cancer. Liver tumours, both primary and metastatic, form a large proportion of solid tumours with a variety of therapeutic options.
